No abstract

finding up to age 64 years and screening for age 65 years and above. There are limitations with forearm scanning, and relatively small numbers of patients have been studied. We would suggest that further research is indicated and that our data contradicts the suggestion that 71 years is an appropriate cut-off age for screening. Other countries 3 have already adopted 65 years as a sensible age above which BMD testing should take place. Regardless of additional risk factors, a larger UK-based study is needed.

No abstract

No abstract

No abstract